Showing 1 - 10 of 545
This paper explores different empirical strategies to examine the effect of cost sharing for prescription drugs in some dimensions of medication-related quality, namely the probability of inappropriate prescription drug use among United States seniors. Using data from 1996 to 2005, we explore...
Persistent link: https://www.econbiz.de/10003951612
We analyze prescription behavior of physicians in the public and private sector. We study two major diseases for which … private sector physicians are more likely to prescribe the expensive medication. The result holds after controlling for … our cases, we further find that the same physicians prescribe different medication when working in different sectors …
Persistent link: https://www.econbiz.de/10013482204
condition for designing effective policies is to identify who drives antibiotic treatment decisions, physicians or patient … demand. We measure the causal effect of physician practice style on antibiotic intake and health outcomes exploiting …
Persistent link: https://www.econbiz.de/10012599029
structural model for the three drugs, covering demand and price setting, is estimated in a joint maximum likelihood approach. We … national insurance. -- pharmaceuticals ; discrete choice model ; funding-schemes …
Persistent link: https://www.econbiz.de/10009377790
We analyse how a patent-holding pharmaceutical firm may strategically use advertising of existing drugs to affect R&D investments in new (differentiated) drugs, and thereby affect the probability distribution of future market structures in the industry. Within a fairly general model framework,...
Persistent link: https://www.econbiz.de/10003771873
Competition among physicians is widespread, but compelling empirical evidence on the impact on service provision is …
Persistent link: https://www.econbiz.de/10011734380
Using an extensive longitudinal dataset extracted from the Norwegian Prescription Database (NorPD) containing all prescriptions written in the period January 2004 to June 2007, we selected two particular drugs (chemical substances) used against cholesterol. The two brand-name products on the...
Persistent link: https://www.econbiz.de/10008697144
entry by generic producers. Reference pricing shifts demand towards generics but also induces the branded producer to become …
Persistent link: https://www.econbiz.de/10013285854
We examine the strategic interaction in the market for physician services when the total budget for reimbursement is fixed. We show that this prospective payment system involves { compared to a fee-for-service remuneration system { a severe coordination problem, which potentially leads to the...
Persistent link: https://www.econbiz.de/10011398025
Incentive contracts for gatekeepers who control patient access to specialist medical services provide too weak incentives to investigate cost further when expected cost of treatment is greater than benefit. Making gatekeepers residual claimants with a fixed fee from which treat-ment costs must...
Persistent link: https://www.econbiz.de/10011511048